Elicio Therapeutics Inc. (ELTX)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Robert T. Connelly
Employees:
23
451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
(857) 209-0050
-
Formally known as:
- Angion Biomedica Corp
Date | Ratio |
---|---|
2023-06-02 | 1:10 |
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company was formerly known as VEDANTRA PHARMACEUTICALS, INC. and changed its name to Elicio Therapeutics Inc. on September 18, 2019. The company was incorporated in 2011 and is headquartered in Boston, Massachusetts.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|